Malignant Nasopharyngeal Neoplasm — Trials

Malignant Nasopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 261
Recruiting: 139
Ph III recruiting: 56
Growth YoY: +5.2%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 24.1%
Trials / 1,000 deaths: 376.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 151–167 of 167 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05652192	SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC	recruiting	Phase 2	37	Zhejiang Cancer HospitalOTHER	1	Dec 15, 2022	clinicaltrials
NCT05628922	Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT	recruiting	Phase 2	198	Fudan UniversityOTHER	1	Nov 29, 2022	clinicaltrials
NCT05514275